UK approved the Biontech / Pfizer vaccine.
The corona vaccine of the Swedish-British group AstraZeneca is being checked again.
The UK
has approved the
corona vaccine *
from
Biontech
and
Pfizer *
.
US immunologist
Anthony Fauci
described the
corona vaccines *
as "cavalry" in the fight against the pandemic *.
Health Minister
Jens Spahn
and Vice Chancellor
Olaf Scholz
expect the first vaccinations in
Germany
as early as December.
This news ticker is updated regularly.
Update from December 2nd, 9:10 a.m .:
The time has come!
The corona vaccine from partners
Biontech
and
Pfizer
has been
approved
in the
UK
.
The UK government granted the emergency license application.
The Mainz company and its US partner are now allowed to offer their vaccine in the first country ever.
The vaccine is available for immediate delivery - Britain plans to start vaccinations as early as next week.
The procedure for
approval in the
EU
is still ongoing.
The European Medicines Agency
Ema
wants to
decide on a recommendation for approval for the European market
by
December 29th
at the latest
.
"As a company based in the heart of Europe, today's milestone is immensely important to us as we continue to strive to enable global distribution after the potential approval of BNT162b2," said Biontech boss
Ugur Sahin
*.
Approval is also imminent
in the
USA
.
The US government announced that approval could take place in the first two weeks of December.
Corona vaccine: Great Britain wants to approve first vaccine
Update from November 28, 7.11 p.m.:
Great Britain wants to
approve
the corona vaccine from Biontech and Pfizer as early as next week.
This would make the UK the first western country with a verified vaccine.
Once approved, the drug could be delivered and distributed within hours.
The
Financial Times
claims to have found out from government circles.
The first vaccinations should take place
on
December 7th
.
Great Britain is said to have ordered 40 million vaccine doses.
Biontech and Pfizer developed the vaccine BNT162b2.
It promises 95 percent effectiveness.
The German Biontech boss
Ugur Sahin
*
and his wife
Özlem Türeci
did research on vaccine development.
UK regulator set to approve Covid-19 vaccine next week https://t.co/p5rBdC6xIw
- Financial Times (@FT) November 28, 2020
Update from November 27, 4:50 p.m.:
On Friday,
Thailand
signed a contract with the British-Swedish pharmaceutical company
Astrazeneca
for the delivery of
26 million vaccine doses of
the
corona vaccine
AZD1222.
The vaccine should be available to the Southeast Asian country with its 69 million inhabitants in
mid-2021
, reported the
Bangkok Post
newspaper
.
A
research
fund
is also planned
so that the agent can also be produced in Thailand.
Prime Minister
Prayut Chan-o-cha
stressed on Thursday that he hoped
to be able to open up
the country to
mass tourism
again
.
"The more we push this schedule, the sooner we can open our doors to a large number of visitors and
start
rebuilding our economy
."
Corona: Doubts about study design and high effectiveness of the Astrazeneca vaccine
Update from November 27th, 3:10 p.m.:
The
British regulatory authority for drugs
is to
review
the
corona vaccine of
the pharmaceutical company
AstraZeneca
on behalf of the government
.
This is a "first, important step in the approval of the vaccine, if it meets the safety, effectiveness and quality standards," said the Ministry of Health in
London
on Friday
.
"We have formally asked regulators
to evaluate
the
vaccine
, understand the data and determine whether it
meets
strict safety standards
," said Health
Secretary
Matt Hancock
.
"We're working tirelessly to be in the best possible position to deliver a vaccine once it's approved by the independent MHRA regulatory agency."
We've formally asked the independent regulator @MHRAgovuk to assess the @ UniofOxford / @ AstraZeneca vaccine to determine if it meets rigorous safety standards.
We're working hard to be in the best possible position to deploy a #coronavirus vaccine as soon as one is approved.
- Matt Hancock (@MattHancock) November 27, 2020
Previously,
doubts had
arisen
about the study design
and the
high effectiveness of
the vaccine.
The Swedish-British group is therefore planning
additional investigations
.
A spokeswoman for
AstraZeneca
told
the
dpa
in London that
they should "supplement the data from existing studies"
without giving details.
According to
Pascal Soriot
, the head of the British-Swedish pharmaceutical company,
results of
90 percent effectiveness were obtained
in a group of
test
persons
.
The test subjects initially received
half a dose
and a month
later a full dose of
the vaccine.
A
second test group
had received the full active ingredient twice - but here the effectiveness was only
62 percent
.
The problem: in the group of
study participants
who were given a low dose,
nobody was over 55 years old
, reports
Bild
.
It
is therefore not known
whether the
vaccine will also be
as effective in high-
risk groups
.
Soriot
announced that the
new study would test
the effectiveness of the vaccine at the lower dose.
Corona vaccine: Moderna wants to start delivery in December
Update from November 26th, 11.49 a.m.:
The US manufacturer
Moderna
wants to start delivering its
corona vaccine
to the
European Union
as early as December - provided the agent receives approval.
The company announced this on Wednesday.
It confirmed the conclusion of a
framework agreement
with the EU Commission.
Accordingly,
80 million vaccine
doses are to be delivered
initially
, with the option of 80 million more units.
We just announced that the European Commission has approved an agreement to secure 80 million doses of mRNA-1273, with the option to increase their purchase to a total of up to 160 million doses.
Read more: https://t.co/G5wLVcGR51 #mRNA pic.twitter.com/lSTZQ5eMAt
- Moderna (@moderna_tx) November 25, 2020
"
Moderna
is assuming that it will start delivering mRNA-1273 to the European Union in December 2020", the company confirmed at the request of the
dpa
.
Strategic partners in Europe are
Lonza
in
Switzerland
and
Rovi
in
Spain
for the production and filling of the
vaccine
.
Corona vaccine: "Vaccine is not a magic potion" - Hofreiter calls for solidarity
The Bavarian Prime Minister
Markus Söder spoke
about the
Corona
vaccine
after the
Corona summit
on Wednesday
.
"The vaccine works, but it's not a magic potion and it doesn't just give you the caution and prudence we need," he said.
In
his speech in the
Bundestag
on Thursday,
Greens parliamentary group leader
Anton Hofreiter
called for
solidarity
with the global
distribution of corona vaccines
.
"The question will be whether the global right or wrong of the fittest applies, or whether we distribute the vaccines in solidarity," he said.
That will burn into billions of people and decisively
shape
the
international order
for the next few years, emphasized
Hofreiter
.
"We have a great
opportunity as rich countries, as the West, to ensure solidarity."
Corona vaccine: Chinese manufacturer applies for approval
Update from November 25, 1:25 p.m.:
According to a report by the Chinese news agency
Xinhua Finance
on Wednesday, the first manufacturer in
China has applied
for
approval of a corona vaccine
for the general public.
The vaccine developer
China National Biotec Group (CNBG)
had submitted an application for approval of its preparation to the authorities
, it said.
The agency relies on a manager of the CNBG parent company
Sinopharm
.
It
is difficult to
compare the
corona vaccine
with that of the western manufacturers.
Neither
CNBG
nor
Sinopharm
have
made
any
more precise data on the effectiveness of their vaccine.
According to its own information from last week, Sinopharm has already
vaccinated
almost one million people
against the
coronavirus
using a so-called
emergency program
with its
vaccine candidates
.
There have been no reports of serious side effects.
Only a few people would have developed mild symptoms.
Chinese state media have been
reporting on
vaccinations for
certain population groups
for weeks
.
Military personnel and hospital staff, as well as diplomats and employees of state corporations are
vaccine candidates
administered the
test
in clinical trials
not completed
is.
Corona: Opel offers factory space for regional vaccination centers
Update from November 25, 8:34 a.m.:
The car manufacturer
Opel
has offered the states of
Hesse
,
Rhineland-Palatinate
and
Thuringia
to
set up
regional corona vaccination centers
in their plants
.
Areas and buildings are ready, said Opel boss
Michael Lohscheller
on Wednesday of the
dpa
.
"With large factory halls and parking areas as well as good connections to the local public transport network, our locations have excellent logistical prerequisites to specifically support and facilitate the
vaccination process
as soon as a
vaccine is
available", Lohscheller promoted his idea.
In addition to the headquarters in
Rüsselsheim
near Frankfurt, the car manufacturer also has plants in
Kaiserslautern
and
Eisenach
.
In Rüsselsheim the site is oversized, so parts have already been sold.
The
Opel boss
described the fight against the
Covid-19
disease
as a task for society as a whole, in which everyone had to help.
He said: “We want to do our part.
Because people's health has top priority. "
Corona: FDP parliamentary group leader Lindner demands "offensive for vaccination protection"
Update from November 24th, 5:50 pm:
With a view to the corona pandemic, FDP parliamentary group leader
Christian Lindner has
demanded
an
"offensive for vaccination protection"
from the federal government
.
"The willingness to be vaccinated is still too low measured by the degree of threat and the restriction of freedom," said Lindern on Tuesday in
Berlin
before a meeting of the FDP parliamentary group.
"It is the responsibility of the federal government to work now to ensure that people get vaccinated."
Initially, however, the deliberations of Chancellor Angela Merkel and the Prime Ministers of the federal states on Wednesday (November 25th) will be the focus.
The first details leaked out even before the Corona summit.
Corona vaccine: EU Commission signs framework agreement with Moderna
Update from November 24th, 1:45 p.m.:
The
EU Commission
has
negotiated
a framework agreement for
up to 160 million doses of
the
corona vaccine from
the US company
Moderna
.
The Commission chief
Ursula von der Leyen announced
on Tuesday.
The contract is to be formally sealed on Wednesday.
The
EU Commission
now has contracts with the manufacturers of all three
corona vaccines
, which are given the best chances for rapid approval in the coming weeks.
In addition to
Moderna
, these are
Biontech / Pfizer
and
Astrazeneca
.
All three had
announced
promising test data
in the past few days
.
Accordingly, all three vaccines are effective and well tolerated.
No one has
Corona vaccine
a
European approval
.
The
Federal Government and the EU Commission expect the
first
licenses to
be
issued
in
December
.
Before this, however, an examination by the European Medicines Agency (EMA) is necessary.
Tomorrow we will approve a 6th contract for up to 160 million doses of the @moderna_tx vaccine.
We're building one of the most comprehensive # COVID19 vaccine portfolios in the🌍Safe & effective vaccines can help us end the pandemic.
https://t.co/ymfqmMLWIJ
- Ursula von der Leyen (@vonderleyen) November 24, 2020
The
EU Commission
concludes
framework agreements
with manufacturers
on behalf of the 27 member states
.
On the one hand, these contracts contain advance payments so that the pharmaceutical companies can set up production quickly, and on the other hand, rights of first refusal for the EU countries.
Once a drug has been approved, all 27 states are to have
access to
it
at the same time
, although initially only in small quantities depending on production capacity.
They are distributed in the EU
according to the size of the population
.
Germany
has a share of
18.6 percent
.
In Germany, on the other hand,
risk groups
and
health workers
are
likely to be
vaccinated first.
It will be months before everyone gets the chance to get a vaccination.
Corona vaccine: According to the manufacturer, "Sputnik V" is 95 percent effective
Update from November 24th, 12:17 pm
: According to its manufacturer, the Russian corona vaccine "Sputnik V" is 95 percent effective.
This is the result of a second interim analysis of the data from clinical studies, announced the Russian Ministry of Health, the state research center Gamaleja and the Russian state fund RDIF in a joint statement on Tuesday.
Almost two weeks ago, Russia reported a 92 percent effectiveness of "Sputnik V".
The analysis is based on preliminary data from patients who had received the first dose of the vaccine 42 days earlier, the statement said.
However, it remained unclear how many test cases had been taken into account.
Russia had already approved "Sputnik V" in August without waiting for the final test phase with the tens of thousands of test subjects.
The second vaccine, "EpiVacCorona", was approved in mid-October.
Corona vaccine | effectiveness | storage | Vaccine type |
---|---|---|---|
Sputnik V (Russia) | 95 percent effective | dry form of the vaccine can be stored at 2 to 8 degrees | Adenovirus-based vector virus vaccine |
Pfizer Biontech vaccine (USA, Germany) | 95 percent effective | Storage at minus 70 degrees | mRNA vaccine |
Moderna (USA) | 94.5 percent effective | Storage probably at minus 70 degrees | mRNA vaccine |
AstraZeneca and Oxford University (Sweden, UK) | 70 percent effective | Refrigerator temperature of two to eight degrees | Vector virus vaccine |
+
"Sputnik V" - Russia reports 95 percent effectiveness of corona vaccine.
© Sputnik
Corona vaccine: First airline wants to introduce mandatory vaccination for passengers
Update from November 24th, 7:22 am:
"We will require international travelers to be vaccinated before we let them on board," said
Alan Joyce
, head of the Australian airline
Qantas
, in an interview with the broadcaster
Nine News
on Monday.
Concerned about the further spread of the
corona virus
, the company wants to
introduce
compulsory vaccination for passengers
on intercontinental connections.
A decision has not yet been made on how to proceed with domestic flights.
As soon as a
vaccine is
available, the
airline's
terms
and conditions will be adjusted accordingly,
Joyce
said
.
He assumes that his airline is not alone in this, but that
similar rules will be
introduced worldwide.
"I think this will be a normal thing, judging from conversations with my colleagues from other airlines."
#BREAKING: QANTAS CEO confirms that proof that you've been vaccinated for COVID-19 will be compulsory for international air travel onboard his aircraft.
# 9ACA pic.twitter.com/dhk3Hsnxn9
- A Current Affair (@ ACurrentAffair9) November 23, 2020
Corona vaccine: Health Minister Spahn visits IDT Biologika
Update from November 23, 9.42 a.m.:
Health Minister
Jens Spahn
and
Reiner Haseloff
, Prime Minister of Saxony-Anhalt, inform during their visit to the vaccine manufacturer
IDT Biologika
in Dessau-Roßlau in a press conference about the state of research.
The two politicians answer questions after a tour of the company.
Alongside
CureVac
and
BioNTech,
IDT
is
the third German company * that is
raising
hopes for successful coronavirus vaccines.
The federal government wants to secure at least five million vaccine doses from IDT, said Spahn.
130 million euros would be made available in research funds, an additional 30 million would be invested in the company in advance in order to secure production.
There is reason to hope that vaccinations against Sars-CoV-2 can be started at the beginning of next year, possibly even at the end of this year, the Minister of Health continued
(see also update 7.10 a.m.)
.
The vaccine from IDT will only be available later than the preparations from the other companies.
Corona vaccine: Next breakthrough company - 70 percent effectiveness
Update from November 23, 8:34 a.m.:
Next breakthrough in
vaccine research
in the fight against the novel
coronavirus Sars-CoV-2
: Another company, the British-Swedish pharmaceutical company
Astrazeneca has presented
positive data on a corona vaccine that is intended for Europe is relevant.
The vaccine avoids with around
70 percent probability
of contracting
Covid-19
, the company announced on Monday based on data from the important test phase III.
The effectiveness of the vaccine is, however, behind that of the preparations from Pfizer / Biontech and Moderna.
The vaccine was developed together with Oxford University.
Both single and double vaccination data were taken into account.
According to preliminary data, the effectiveness of the vaccines from Pfizer / Biontech and Moderna is around 95 percent for double vaccinations.
Advantage of the Astrazeneca vaccine
: According to the information, the preparation can be stored at refrigerator temperatures of two to eight degrees.
The
active ingredient AZD1222
is based on the weakened version of a
chimpanzee cold
virus
.
It contains genetic material from a surface protein with which the Sars-CoV-2 pathogen docks onto human cells.
The agent works in two ways: It is supposed to promote the formation of specific antibodies as well as T cells - both are important for the immune system.
Unlike the vaccines from the Mainz company Biontech and the pharmaceutical company Pfizer as well as the US company Moderna, the British-Swedish preparation does not belong to the mRNA vaccines.
Corona vaccinations earlier than expected?
"Reason for optimism": Spahn and Scholz name a possible time for corona vaccinations
Update from November 23, 7:10 am:
“There is reason to be optimistic that a vaccine will be approved in Europe this year.
And then we can start immediately with the vaccinations, ”said Federal Minister of Health
Jens Spahn to
the
editorial network Germany
.
He asked the federal states that the
vaccination centers
should be
ready for use in
mid-December
.
That seems to work.
Finance Minister
Olaf Scholz
also raised hopes for
corona vaccinations
this year.
"We have made the preparations so that it could start in December," said the Vice Chancellor on Sunday evening on
Bild live
.
He thinks that “the vaccination starts faster than we thought some time ago,” emphasized
Scholz
.
Spahn
was optimistic that it would
not take until the end of 2021
for
all population groups to be vaccinated
.
For example, many of the likely vaccines
do not require deep cooling
.
They could be given in normal
doctor's offices
.
"And then it goes quickly: Let's not forget that in a few weeks up to 20 million people are vaccinated against flu every year," said Spahn.
Corona vaccine: Spahn announces the establishment of an online platform
He also announced the
establishment of an online platform
on the
vaccination rates
achieved
, differentiated according to
age
and
region.
"Especially if we have achieved a high vaccination rate among the particularly vulnerable population groups, we will be able to gradually relax the restrictions."
According to
Spahn
,
Germany
has
now
secured
more than 300 million vaccine doses
for Germany
through the
EU Commission
or bilateral agreements and options
.
"Even with two doses per vaccination, we would have enough for our own population and could share it with other countries," said Spahn.
The Minister of Health announced that Germany will also
secure
vaccination doses from the Dessau vaccine manufacturer
IDT
.
He and Saxony-Anhalt's Prime Minister
Reiner Haseloff visited
the manufacturer on Monday.
Corona vaccine: Research Minister reaffirms security
Update from November 21, 9:05 a.m.:
Federal Research
Minister
Anja Karliczek
has
emphasized
the safety of the new potential
corona vaccines
.
"The vaccine will meet the same safety standards as all the others," Karliczek told the
Neue Osnabrücker Zeitung
.
"This also means that the authorities will continue to provide close support after approval and have an eye on the
safety
and
effectiveness of
the vaccine - exactly how it usually works." She added: "So nobody needs to worry." Karliczek emphasized: "The
vaccination remains absolutely voluntary
."
Corona vaccine: Biontech and Pfizer have applied for emergency approval
Update from November 20, 9:55 p.m.: Biontech
and
Pfizer
had already announced it, now the two companies have
actually applied for
emergency
approval
for their
corona vaccine
from the US FDA.
Pfizer confirmed this on Friday on Twitter.
If the active ingredient is approved, particularly vulnerable people in the
USA
could be
vaccinated as early as mid to late December.
"Applying for an emergency license in the US is a crucial step in making our vaccine candidates
available to
the
world's population
as quickly as possible
," said Biontech co-founder
Ugur Sahin
.
Pfizer boss
Albert Bourla
spoke in an Internet video of a "historic day for science and all of us".
We are submitting our first request for an #EUA in the US for vaccine candidate # BNT162b2 against # covid19.
We look forward to continuously providing data to various regulatory authorities as part of our rolling review process - including the @EMA_News.
https://t.co/Lk7MTlwE5R pic.twitter.com/OjZ2IxiU3a
- BioNTech SE (@BioNTech_Group) November 20, 2020
Corona vaccine: Olaf Scholz calls for global solidarity
Update from November 20, 4:50 p.m.:
Finance Minister
Olaf Scholz
has called on the leading
economic
nations
to participate
in the international
Covax corona vaccination initiative
.
"Germany and Europe have already pledged substantial financial
resources
here," said the Vice Chancellor after consultations with the
G20
finance ministers on Friday.
Germany
is the second largest donor.
But: "It is necessary that all G20 countries participate," explained
Scholz
.
According to the Ministry of Finance, a total of
around 4.3 billion euros has been made available
for the
development
and globally
fair distribution
of
corona vaccines
.
The latest news on this gave hope, said
Scholz
.
A
global
alliance is now
necessary to ensure fair and equitable access to vaccines.
Corona vaccine: USA plans delivery within 24 hours of approval
First report from November 20:
Munich / Washington - In the past few days, several companies have reported great successes in developing their
corona vaccine
.
Chancellor
Angela Merkel
spoke on Thursday evening that a vaccine could be approved in Europe in December or “very quickly after the turn of the year”.
The Mainz company
Biontech *
and its US partner
Pfizer
want to
apply for
state emergency approval
in the
US
for their
corona vaccine
on Friday
.
“We will be shipping millions of vaccine doses within 24 hours of FDA approval.
So my message is: Hope and help are on the way, "said US
Secretary of
Health
Alex Azar
at a briefing for the
coronavirus *
task force of
the White House on Thursday.
The government hopes that if the decision is positive,
millions of doses of the vaccine
could be available before the end of the year.
Azar also
reported that it is expected that the American vaccine developer
Moderna will
also soon ask for permission for its vaccine.
He praised the work of the scientists.
"In the past two weeks we have seen
unprecedented historical news
about vaccines," said the US Secretary of Health.
Most recently, there were
more than 2,200
corona deaths
in just one day
in the
United States
.
Corona vaccine: "Operation Warp Speed" is intended to ensure rapid distribution
“The goal is to make this vaccine as convenient for people to distribute as the flu vaccine,” said
Azar
.
A
comprehensive distribution plan
, based on a public-private partnership, is already in place.
Army General
Gustave Perna
, head of this so-called
"Operation Warp Speed"
, assured that there would be
no delivery bottlenecks
.
“We can ship the vaccine doses anywhere a US state wants to give them.
You can go to one central location or 10,000 different locations, ”he said.
Around 100 million vaccine containers are already ready.
Once Emergency Use Authorization comes, "24 hours later, vaccines will be distributed to the American people and be ready for administration."
pic.twitter.com/3m2gSSJduh
- The White House (@WhiteHouse) November 19, 2020
Coronavirus: US immunologist Fauci describes vaccine as "cavalry" in the fight against the pandemic
The renowned US immunologist
Anthony Fauci
also spoke about the
corona vaccines *
at the briefing
.
"The speed of the process has not compromised security in any way," he affirmed.
Fauci rejected concerns that the development of
corona vaccines
should have been accelerated at the expense of tolerability and effectiveness.
The data from the studies on the vaccines were
judged
by
independent experts
who owed no one, including the government.
Fauci
called on the American people to
continue to follow
the "simple"
measures
to prevent
corona infections *
.
You should wear masks, keep your distance and avoid crowds.
He described the effective
corona vaccines *
as the "cavalry" in the fight to contain the
pandemic
.
“When you are fighting in a battle and the cavalry is on the way, you don't stop shooting.
You keep going until the cavalry is there - and then you might want to keep fighting, ”said Fauci.
(ph) * Merkur.de is part of the Ippen-Digital editorial network
List of rubric lists: © picture alliance / Marcus Brandt / dpa